Axovant Sciences Ltd. 4
4 · Axovant Sciences Ltd. · Filed May 2, 2017
Insider Transaction Report
Form 4
OLANOFF LAWRENCE S
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-04-28+27,000→ 27,000 totalExercise: $24.24Exp: 2027-04-28→ Common Shares (27,000 underlying)
Footnotes (2)
- [F1]100% of this option will vest one year after the date of grant. The option allows for early exercise, subject to the issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F2]Includes only options with the same termination date.